IN2015KN00416A - - Google Patents

Info

Publication number
IN2015KN00416A
IN2015KN00416A IN416KON2015A IN2015KN00416A IN 2015KN00416 A IN2015KN00416 A IN 2015KN00416A IN 416KON2015 A IN416KON2015 A IN 416KON2015A IN 2015KN00416 A IN2015KN00416 A IN 2015KN00416A
Authority
IN
India
Prior art keywords
pfs47
mosquito
gambiae
falciparum
parasites
Prior art date
Application number
Other languages
English (en)
Inventor
Carolina Veronica Barillas-Mury
CRUZ Alvaro MOLINA
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IN2015KN00416A publication Critical patent/IN2015KN00416A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN416KON2015 2012-08-17 2013-08-16 IN2015KN00416A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261684333P 2012-08-17 2012-08-17
PCT/US2013/055372 WO2014028852A1 (fr) 2012-08-17 2013-08-16 Utilisation de p47 de plasmodium falciparum (pfs47) ou de plasmodium vivax (pvs47) comme vaccin ou cibles de criblage de médicaments pour l'inhibition de la transmission de la malaria humaine

Publications (1)

Publication Number Publication Date
IN2015KN00416A true IN2015KN00416A (fr) 2015-07-17

Family

ID=50101528

Family Applications (1)

Application Number Title Priority Date Filing Date
IN416KON2015 IN2015KN00416A (fr) 2012-08-17 2013-08-16

Country Status (6)

Country Link
US (1) US20150203547A1 (fr)
EP (1) EP2885410A4 (fr)
CN (1) CN104736710A (fr)
BR (1) BR112015003184A2 (fr)
IN (1) IN2015KN00416A (fr)
WO (1) WO2014028852A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018157083A1 (fr) 2017-02-24 2018-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions et méthodes pour bloquer la transmission du plasmodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077195A2 (fr) * 2001-03-26 2002-10-03 Walter Reed Army Institute Of Research Proteine ama-1 de plasmodium falciparum et ses applications
CN102264381B (zh) * 2008-10-01 2014-07-09 美国政府(由卫生和人类服务部的部长所代表) 提供对疟原虫的长效免疫应答的用于疟疾的多组分疫苗
DK2763694T3 (en) * 2011-10-04 2018-04-16 Statens Seruminstitut Preparation of a cysteine-rich protein

Also Published As

Publication number Publication date
BR112015003184A2 (pt) 2018-05-08
CN104736710A (zh) 2015-06-24
WO2014028852A1 (fr) 2014-02-20
US20150203547A1 (en) 2015-07-23
EP2885410A1 (fr) 2015-06-24
EP2885410A4 (fr) 2016-03-23

Similar Documents

Publication Publication Date Title
MX2023014569A (es) Anticuerpos anti-sirpa.
MD3718565T2 (ro) Vaccinuri împotriva virusului respirator
EP3408392A4 (fr) Éradication du virus jc humain et d'autres polyomavirus guidée par un arn
MX2014004814A (es) Compuestos y metodos para mejorar las respuestas inmunes innatas.
WO2018193063A3 (fr) Nouveaux vaccins contre le paludisme et anticorps se liant aux sporozoïtes de plasmodium
IN2014CN04187A (fr)
WO2016210384A3 (fr) Bactéries manipulées pour traiter des maladies métaboliques
WO2017066706A8 (fr) Souches recombinées vaccinales de listeria et leurs méthodes d'utilisation en immunothérapie anticancéreuse
WO2015052543A3 (fr) Vaccination antipaludique
EA201790507A1 (ru) Способы и композиции для усиления иммунных ответов
PH12014501388A1 (en) A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv
EA201300132A1 (ru) Фармацевтическая композиция и методы лечения и профилактики заболеваний, вызванных вич или ассоциированных с вич
WO2015123493A3 (fr) Compositions et méthodes de modulation de réponse immunitaire
WO2015054678A3 (fr) Vaccin thérapeutique contre le papillomavirus humain
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
GEP20197052B (en) Hyr1-derived compositions and methods of treatment using same
PH12015502844A1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
WO2014140166A3 (fr) Vaccin
WO2013108272A3 (fr) Vaccin antipaludique ciblant le stade sanguin
NZ606563A (en) Bacterial ghosts for mediating innate immunity
IN2014DN09445A (fr)
IN2015KN00416A (fr)
GB201112587D0 (en) Vaccine
PH12018500201A1 (en) Enhanced immune response in porcine species